Giving an inpatient oral glucose tolerance test before delivery discharge for women with gestational diabetes tripled the ...

There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...

The study was carried out at 24 clinical sites across the UK and included 303 participants.

The study evaluates artificial sweeteners' role in appetite regulation, showing no significant effects on hunger or energy ...

Swayable, the causal AI platform used by the world's top brands to measure the impact of their messaging, today announced that CEO Dr. James Slezak has been appointed to the Advertising Research ...

Twelve photovoltaic storage systems with capacities of 5 kW or 10 kW were included in the comparison, among them several new products, all of which achieved efficiency class A. A new study – also ...

Implementing a simple exercise plan during chemotherapy may ease cognitive impairment and fatigue, promoting better health outcomes for cancer patients.

Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2025 Earnings Call Transcript March 18, 2026 Sera Prognostics, Inc. beats earnings expectations. Reported EPS is $-0.15768, expectations were $-0.18897.

As we shared last year, to support Sera Prognostics, Inc.'s next phase of commercialization, we strengthened our leadership team with Lee Anderson joining us as Chief Commercial Officer and Doctor ...

Intrinsic Therapeutics, Inc. has introduced the Barricaid ® Narrow Anchor, the next generation of its FDA PMA-approved Barricaid ® Bone-Anchored Annular Closure Device. The new version of the ...

Public health has its own bracket of champions: breakthroughs that eliminated deadly diseases, revolutionized surgery, and opened entirely new doors in medicine. From vaccines to mRNA technology, ...